ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135037; 2) Community: the network communities that were significantly associated with the response to NSC 135037; 3) Molecule: the relationships between components within communities and NSC 135037; 4) MDR: the compounds that were significantly associated with the NSC 135037.

NSC Compound Enrichment Correlation
NSC 140377 Arnebin 1 0.000135256398432179 0.81023473
NSC 321521 SK&F 39162 0.000135256398432179 0.42492693
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.000135256398432179 0.65643004
NSC 352330 Bis(helenalinyl)glutarate 0.000166573147098352 0.83815277
NSC 635831 Null 0.000166573147098352 0.59336087
NSC 704886 2-Butenedioic acid, 2-[5-chloro-2,4-dioxo-3-(2-propynyl)-1H,3H-pyrimidinyl]-,diethyl ester, (2E)- 0.000166573147098352 0.69693552
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.000166573147098352 0.76279187
NSC 651590 ANTINEOPLASTIC-651590 0.000216242727122388 0.74469548
NSC 662383 2-Bromo-5,8-dihydroxy-3-methyl-1,4-naphthoquinone 0.000216242727122388 0.80478909
NSC 672120 Oxireno[9,10]cyclodeca[1,2-b]furan-6,9(7H,10aH)-dione, 1a,2,3,7a,8,10b-hexahydro-1a,5-dimethyl-8-methylene-, stereoisomer 0.000281397700245212 0.83579627
Total:92  Current:1    [First] [Prev] [Next] [Last]